<This is why the terms that GTC gets from its past partners can be used to determine true market cap value.>
Of course that is a gross simplification and misrepresentation. Didn't you ever hear the phrase "past performance does nto guarantee future results". Each deal will differ depending on what product is being partnered. In addition, previous deals came prior to EMEA approval of rATIII. Following FDA approval of rATIII, the metric for deals will once again shift in GTCB's favor for futurer partnerships.
Market Data 
Markets 
AI
